Insulin Resistance Test vs Fasting Insulin Test Explained

November 19, 2026
Insulin Resistance Test vs Fasting Insulin Test Explained

Not exactly. A fasting insulin test measures the amount of insulin circulating in your blood after an overnight fast. An insulin resistance test is a broader term that may refer to fasting insulin, fasting glucose and a calculated HOMA-IR score.

The two often overlap, but they aren't interchangeable. The key difference is what each test measures, what it can tell you about your metabolic health, and whether you should interpret the results alongside other risk factors.

Insulin Resistance Test vs Fasting Insulin Test: Key Differences

Fasting Insulin TestInsulin Resistance Assessment
What it measuresInsulin levels after fastingOne or more measures used to estimate insulin resistance
Common markersFasting insulinFasting insulin, fasting glucose and sometimes HOMA-IR
Fasting requiredUsually 8–12 hoursUsually, when fasting insulin is included
Main purposeAssess fasting insulin concentrationsAssess possible reduced insulin sensitivity
Can it diagnose insulin resistance?No, not independentlyNo single routine blood test provides a definitive diagnosis

An insulin resistance assessment isn't a standardised laboratory package. The tests included can differ, so it's important to check the individual markers rather than relying on the product name.

What Does a Fasting Insulin Test Measure?

A fasting insulin test measures how much insulin is present in your blood after an overnight fast. Insulin is a hormone produced by the pancreas that helps your body's cells absorb glucose and regulate blood sugar. When cells become less responsive to insulin, the pancreas may compensate by producing more insulin to keep blood glucose levels within the normal range. This means elevated fasting insulin can sometimes appear before fasting glucose becomes abnormal.

However, a high insulin result doesn't automatically confirm insulin resistance. Insulin concentrations vary with individual physiology, medications, laboratory methods and other factors.

Likewise, normal fasting insulin levels don't necessarily rule out reduced insulin sensitivity. Results need to be interpreted alongside glucose measurements, medical history and other metabolic risk factors.

What Does an Insulin Resistance Test Measure?

Insulin resistance develops when the body's cells respond less effectively to insulin. This can make it harder to regulate blood sugar efficiently. Over time, insulin resistance may contribute to impaired glucose regulation, prediabetes and type 2 diabetes.

An insulin resistance assessment may include:

  • Fasting insulin: Measures circulating insulin after fasting.
  • Fasting glucose: Measures blood glucose after an overnight fast.
  • HOMA-IR: Uses both fasting insulin and glucose to estimate insulin resistance.
  • Other metabolic markers: HbA1c, triglycerides and HDL cholesterol may provide additional information about metabolic health.

An oral glucose tolerance test (OGTT) can also assess how blood glucose responds to a glucose drink, although it measures glucose tolerance rather than insulin resistance directly.

These tests answer related but different clinical questions.

What Is HOMA-IR, and Why Does It Matter?

HOMA-IR stands for Homeostasis Model Assessment of Insulin Resistance. It combines fasting insulin and fasting glucose measurements into a calculated score. When glucose is measured in mmol/L and insulin in mIU/L, the formula is:

HOMA-IR = (Fasting Insulin × Fasting Glucose) ÷ 22.5

HOMA-IR doesn't require an additional blood draw when both measurements are already available. A higher score generally suggests greater insulin resistance, but there is no universally accepted diagnostic cutoff.

Some online resources describe HOMA-IR scores above 2.0 or 2.5 as indicating insulin resistance. These thresholds vary across populations and insulin assays and shouldn't be treated as universal diagnostic rules. HOMA-IR is a useful research measure and may provide additional clinical context in selected patients. However, routine insulin resistance measurement is not recommended for everyone.

Can You Have Insulin Resistance With Normal Blood Sugar?

Yes. Insulin resistance can develop while blood glucose remains within the normal range. In some people, the pancreas initially produces extra insulin to compensate for reduced insulin sensitivity. This can keep glucose levels normal despite changes in insulin regulation.

Insulin resistance may also occur without obvious symptoms. Relevant risk factors include:

These factors don't establish insulin resistance on their own, but they can guide further clinical assessment.

Australian diabetes guidance generally prioritises established glucose-based tests, including fasting glucose and HbA1c, for diabetes screening.

Which Test Should You Choose?

The most appropriate test depends on the question you're trying to answer. If you only need a fasting insulin measurement, a fasting insulin test may be sufficient when your healthcare provider orders it for a specific reason.

If you're investigating possible insulin resistance, your clinician may consider fasting insulin alongside glucose and other metabolic measures, although routine insulin testing isn't necessary for everyone. If you're concerned about diabetes risk, fasting plasma glucose, HbA1c or an OGTT may be more clinically appropriate.

Testing should be guided by your symptoms, risk factors and whether the results will influence treatment or lifestyle recommendations.

How Everlab Approaches Insulin Resistance Testing

Everlab includes fasting insulin and fasting glucose within its Advanced Blood Testing panel, with HOMA-IR calculated from those measurements. Rather than choosing between a fasting insulin test and a separate insulin resistance package, members receive these related markers within the broader assessment.

Everlab's Advanced Blood Testing currently costs $598 and includes more than 90 biomarkers covering metabolic health, cardiovascular health, hormones and other areas. Fasting insulin isn't offered as a standalone test within this service. Everlab doctors review results and interpret them alongside other relevant measurements, rather than using one insulin result as a definitive diagnosis.

Frequently Asked Questions

Is Fasting Insulin the Same as HOMA-IR?

No. Fasting insulin is a measured blood marker, while HOMA-IR is a calculated index using fasting insulin and fasting glucose.

Can I Calculate HOMA-IR From a Fasting Insulin Result Alone?

No. You also need fasting glucose measured during the same fasting assessment, using the appropriate units.

Does a High Fasting Insulin Level Mean I Have Insulin Resistance?

Not necessarily. Elevated fasting insulin may suggest reduced insulin sensitivity, but interpretation depends on laboratory methods, glucose results and clinical circumstances.

Does Everlab Offer a Standalone Insulin Resistance Test?

Everlab includes fasting insulin, fasting glucose, and HOMA-IR in its Advanced Blood Testing panel rather than offering fasting insulin as a standalone test.

The Bottom Line

A fasting insulin test measures one biomarker. An insulin resistance assessment may combine several measures to provide broader information about how your body regulates insulin and glucose. Neither automatically provides a definitive diagnosis of insulin resistance.

For meaningful interpretation, consider the results alongside your clinical history, metabolic risk factors, and established diabetes screening tests.

Explore Everlab's Advanced Blood Testing

This article provides general health information and does not replace advice from your treating healthcare professional. Blood testing should be selected according to individual clinical needs, and results may require further investigation.

Sources

  1. Matthews DR, et al. Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function. Diabetologia, 1985.
  2. Royal Australian College of General Practitioners. Management of Type 2 Diabetes: A Handbook for General Practice.
  3. Teede HJ, et al. 2023 International Evidence-based Guideline for PCOS.
  4. Everlab. Advanced Blood Testing.
Dr Steven Lu
Chief Medical Officer | MBBS (hons) | DCH FRACGP

Steven is a specialist general practitioner, preventative health consultant, medical educator, healthcare entrepreneur and co-founder of Everlab. With 15+ years of clinical experience, and driven by his passion for preventive care outcomes, Steven is dedicated to personalised and innovative approaches to enhance well-being, extend human lifespan, and improve healthspan.

Dr Frank Qian
M.D., BSc (Hons)

Dr. Frankie is a medical doctor, longevity consultant, and elite spearfisherman dedicated to high-performance preventative medicine. A former varsity athlete and kinesiology graduate, he aims to bridge the gap between clinical data and extreme physical mastery. From engineering clinical AI to hunting at 40m depths and chasing world-class strength records, Frankie focuses on practical strategies to optimize healthspan and push the boundaries of human performance.

Future-proof your health.

Join 30,000+ Australians improving their health with proactive, personalised healthcare.
Book a Call

Ready to know your true fitness level?

Your VO₂ Max score is more than a number. It’s a predictor of your long-term health. Join thousands of Australians who’ve already discovered their real endurance potential.

Join today
Green star image
Rated 4.9/5 by Everlab Members
Tested with Clinical-Grade Accuracy
Supervised by Accredited Doctors
“As a triathlete, this test completely changed how I train. The insights are next-level.”
— Daniel H., Sydney
Close-up of a young woman with black hair looking thoughtfully at someone.
40+ blood
markers
Doctor
consultation
Personal risk
roadmap

Book a Free Discovery Call

Join 1000's of Australians improving their health with proactive, personalised healthcare.

Need more info?
Book a call